Furthermore, L1CAM overexpression in these cancer contexts is generally associated with poor prognosis (26, 29–31), an invasive phenotype (32, 33), advanced tumor stages (28, 34), and chemotherapy resistance (35). Here, L1CAM is linked to neoplasm.